Investment objective
ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Funds investment theme of the genomics revolution.
Off-Hours Price |
Change |
YTD change |
Weight | ||
|---|---|---|---|---|---|
 | 53.55USD | -0.81% | +2.12% | 9.96% | |
| 34.60USD | +8.57% | +112.14% | 6.07% | |
| 11.36USD | +12.92% | +42.71% | 5.93% | |
| 33.90USD | +2.11% | +22.29% | 5.12% | |
| 175.09USD | +6.16% | +33.49% | 4.28% | |
| 259.97USD | +10.74% | +13.48% | 4.11% | |
| 136.96USD | +4.69% | +34.09% | 3.94% | |
| 3.230USD | +2.22% | -21.03% | 3.73% | |
| 27.13USD | +8.00% | +44.00% | 3.4% | |
| 15.50USD | +1.64% | +72.41% | 3.35% | |
In partnership with
Description
| US00214Q3020 | |
|---|---|
| Total Expense Ratio | 0.75% |
| Asset Class | Stocks |
| Size | |
| Currency | |
| Provider |
Features and characteristics
| Dividend Policy | Distribution |
|---|---|
| Jurisdiction | |
| Date of creation |
02/04/2019
|
AuM evolution - 27/02/2026
| AuM (USD) | 1.3B |
|---|---|
| AuM 1M | 1.29B |
| AuM 3 months | 1.27B |
| AuM 6 months | 1.05B |
| AuM 12 months | 1.33B |
